new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

International Institute Of Cancer Immunology Inc patents

Recent patent applications related to International Institute Of Cancer Immunology Inc. International Institute Of Cancer Immunology Inc is listed as an Agent/Assignee. Note: International Institute Of Cancer Immunology Inc may have other listings under different names/spellings. We're not affiliated with International Institute Of Cancer Immunology Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | International Institute Of Cancer Immunology Inc-related inventors




Date International Institute Of Cancer Immunology Inc patents (updated weekly) - BOOKMARK this page
03/16/17 new patent  Combination therapy with wt1 peptide vaccine and temozolomide
12/22/16Cancer vaccine composition
08/25/16Tumor antigen based on products of the tumor suppressor gene wt1
07/14/16Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same
06/23/16Cancer antigen helper peptide
06/16/16Method for cancer immunotherapy
04/28/16Wt1 antigen peptide conjugate vaccine
03/24/16Method for predicting clinical effect of immunotherapy
02/25/16Novel cancer antigen eef2
01/14/16Antigen-specific helper t-cell receptor genes
12/17/15Novel cancer antigen eef2
10/15/15Receptor gene for peptide cancer antigen-specific t cell
10/15/15Receptor gene for peptide cancer antigen-specific t cell
08/27/15Wt1 antigen peptide conjugate vaccine
03/19/15Wt1 antigen peptide conjugate vaccine
10/23/14Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
10/23/14Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
09/11/14Receptor gene for peptide cancer antigen-specific t cell
08/14/14Method for measuring anti-wt1 antibody
07/17/14Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
07/10/14Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
07/10/14Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
05/15/14Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same
01/23/14Cancer vaccine composition
10/10/13Method for activating helper t cell
09/19/13Hla-dr-binding antigen peptide derived from wt1
08/29/13Combination therapy with w t 1 peptide vaccine and temozolomide
08/01/13Cancer antigen peptides derived from wt1
08/02/12Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
03/24/11Cancer vaccine composition
07/29/10Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
03/11/10Cancer antigen peptides derived from wt1
12/31/09Wt1 modified peptide
11/12/09Tumor antigen based on products of the tumor suppressor gene wt1
10/22/09Cancer antigen peptide formulations
06/04/09Tumor antigen based on products of the tumor suppressor gene wt1







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with International Institute Of Cancer Immunology Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for International Institute Of Cancer Immunology Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';